Submitted by mphilemon@resea... on Thu, 01/06/2011 - 16:56
Efficacy and Safety of FOLFIRINOX in Patients with Metastatic Pancreatic Cancer
| CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
| Read Dr Love's original email (from January 10, 2011) | Subscribe to Dr Love's email alerts | ||
Slides from a presentation at ASH 2010 and transcribed comments from a recent interview with Rafael Fonseca, MD (12/22/10)
Conroy T et al. Randomized phase III trial comparing FOLFIRINOX (F: 5FU/leucovorin [LV], irinotecan [I], and oxaliplatin [O]) versus gemcitabine (G) as first-line treatment for metastatic pancreatic adenocarcinoma (MPA): Preplanned interim analysis results of the PRODIGE 4/ACCORD 11 trial. Proc ASCO 2010;Abstract 4010.